[Potentiation of hexobarbital action as a method for experimental research on substances with depressive central activity].
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects*; D005260:Female; D006591:Hexobarbital / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007004:Hypoglycemic Agents / Q000494:pharmacology; D051379:Mice; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D012890:Sleep / Q000187:drug effects; D014149:Tranquilizing Agents / Q000494:pharmacology
D000927:Anticonvulsants; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D007004:Hypoglycemic Agents; D009125:Muscle Relaxants, Central; D014149:Tranquilizing Agents; D011335:Proadifen; D006591:Hexobarbital
Il potenziamento dell'azione dell'esobarbitale quale metodo per la ricerca sperimentale di attività depressive centrali.